UCB S.A.: all 580 studies

Page 6 of 6. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic RhinitisCompletedNCT00542607Phase 4
• A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine AttackCompletedNCT00530517Phase 2
• Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic UrticariaCompletedNCT00525382Phase 3
• To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic RhinitisCompletedNCT00525278Phase 3
• Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic RhinitisCompletedNCT00524836Phase 3
• Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of EpilepsyCompletedNCT00522522
• Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.CompletedNCT00521170Phase 1
• Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust MitesCompletedNCT00521131Phase 4
• Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARCompletedNCT00521040Not applicable
• Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in ChildrenCompletedNCT00520754Phase 2
• Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome SubjectsCompletedNCT00498108Phase 3
• Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323TerminatedNCT00484536Phase 2
• Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an AntihistamineCompletedNCT00453583
• An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.CompletedNCT00426673Phase 1
• A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset SeizuresWithdrawnNCT00422110Phase 2/3
• Effect of Brivaracetam in Photosensitive Epileptic SubjectsCompletedNCT00401648Phase 2
• Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy PatientsCompletedNCT00394927
• Study of Epratuzumab in Systemic Lupus ErythematosusCompletedNCT00383513Phase 2
• Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)TerminatedNCT00383214Phase 3
• Study of Epratuzumab in Systemic Lupus ErythematosusWithdrawnNCT00382837Phase 3
• The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom SettingCompletedNCT00381758Phase 4
• A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's DiseaseWithdrawnNCT00358683Phase 3
• Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and AdultsCompletedNCT00357669Phase 3
• Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining FistulasWithdrawnNCT00354367Phase 3
• UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)CompletedNCT00345475
• Cross Sectional Study to Evaluate the Acceptability of Oral Solution of LevetiracetamCompletedNCT00319605
• Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00315523Phase 3
• Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)CompletedNCT00302991
• A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00280696Phase 3
• A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00275236Phase 3
• An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs SyndromeCompletedNCT00263068Phase 3
• Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.CompletedNCT00245713Phase 4
• Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on PrescriptionCompletedNCT00244465
• Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on LevodopaCompletedNCT00244387Phase 3
• A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's DiseaseCompletedNCT00243971Phase 3
• A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's DiseaseCompletedNCT00243945Phase 3
• Rotigotine Restless Legs Syndrome Dose Finding TrialCompletedNCT00243217Phase 2
• A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's DiseaseCompletedNCT00242008Phase 3
• A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic NeuropathyCompletedNCT00238524Phase 3
• An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)CompletedNCT00238511Phase 2
• A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic NeuropathyCompletedNCT00235469Phase 2/3
• A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary GeneralizationCompletedNCT00220415Phase 3
• Levetiracetam in the Treatment of Neuroleptic-induced Tardive DyskinesiaCompletedNCT00175955Phase 2
• A Study of Brivaracetam in Subjects With Partial Onset SeizuresCompletedNCT00175929Phase 2
• Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed EpilepsyCompletedNCT00175903Phase 3
• A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.CompletedNCT00175890Phase 3
• Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.WithdrawnNCT00175864Phase 3
• Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of EpilepsyWithdrawnNCT00175851Phase 3
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With EpilepsyCompletedNCT00160628Phase 3
• A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160602Phase 3
• LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)CompletedNCT00160589Phase 4
• Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome DyskinesiasCompletedNCT00160576Phase 2
• Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic SeizuresCompletedNCT00160550Phase 3
• POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNCT00160537Phase 4
• A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)CompletedNCT00160511Phase 2
• Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese PatientsCompletedNCT00160498Not applicable
• A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)CompletedNCT00152490Phase 3
• Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).CompletedNCT00152425Phase 3
• Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic RhinitisCompletedNCT00152412Phase 2
• Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal BleedingCompletedNCT00152399Phase 2
• A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid ArthritisCompletedNCT00152386Phase 3
• Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POSCompletedNCT00152373Phase 3
• Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial SeizuresCompletedNCT00151879Phase 2/3
• Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.CompletedNCT00150787Phase 3
• Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + AdultsCompletedNCT00150774Phase 3
• Facial Thermography Study of Levocetirizine Versus CetirizineCompletedNCT00150761Phase 4
• Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized EpilepsyCompletedNCT00150748Phase 3
• Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From EpilepsyCompletedNCT00150735Phase 3
• A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic GastroparesisCompletedNCT00139893Not applicable
• A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's DiseaseCompletedNCT00139880Phase 3
• A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's DiseaseCompletedNCT00139867Phase 3
• A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With AnxietyCompletedNCT00139854Phase 3
• A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple SclerosisCompletedNCT00139789Phase 3
• Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg SyndromeCompletedNCT00136045Phase 3
• SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary GeneralizationCompletedNCT00136019Phase 3
• Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00135993Phase 3
• Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic NeuropathyCompletedNCT00135109Phase 3
• Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)TerminatedNCT00113971Phase 2
• Study of Epratuzumab in Systemic Lupus ErythematosusTerminatedNCT00111306Phase 3
• A 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresCompletedNCT00105040Phase 2

← UCB S.A. overview and focus areas